US Patent Issued to Flagship Pioneering Innovations VI on Nov. 18 for "Antigen binding molecules targeting SARS-CoV-2" (Massachusetts, Vermont Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,560, issued on Nov. 18, was assigned to Flagship Pioneering Innovations VI LLC (Cambridge, Mass.).

"Antigen binding molecules targeting SARS-CoV-2" was invented by Gevorg Grigoryan (Arlington, Mass.), John Ingraham (Cambridge, Mass.), Cheuk Lun Leung (Quincy, Mass.), Ross Steven Federman (Dorchester, Mass.), Robin Jeffrey Green (Jamaica Plain, Mass.), Vincent Xue (Winchester, Mass.) and Craig Owen MacKenzie (Bradford, Vt.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides, in various embodiments, polypeptides that specifically bind to Spike glycoprotein of severe acute respiratory syndrome coronavirus (e.g., SARS-CoV-2-Spike). The...